Monograph

S01EE04 - Travoprost

Not porphyrinogenic

Rationale

Insignificant hepatic exposure.

Chemical description

Eyedrops for treatment of glaucoma. Prostaglandin F2 alpha analogue, meablized in the same way as the endogenous prostaglandin by reduction of the 13-14 double bond, oxidation od the 15-hydroxyl group and beta-oxidative breaking of the upper side chain. Low systemic exposure of the free acid, plasma concentration < 25 pg/ml.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes S01E / S01EE or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames